GOVX - קצב צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים GeoVax Corp

The stability of US government grants and the humanitarian status of GeoVax Labs, Inc. (GOVX) have provided a solid foundational base. The 12-month revenue growth trajectory reflects current market dynamics, where -99.90 captures the current value of the indicator. Growth prospects rely on the recruitment of top virologists and the implementation of automated bioplatforms that accelerate immunological testing for the development of new vaccines.
geovax.com (GOVX) - פילוחי מדדים ודוחות פיננסיים

GeoVax Labs, Inc. (GOVX) is protected by patents for its MVA platform, which eliminates price wars with competitors. Revenue dynamics digitize the commercialization efficiency of these developments while awaiting FDA approval. A 12-month rolling window calculation neutralizes accounting noise and the low-base effect, allowing real growth to be separated from one-time receipts. By analyzing the YoY dynamics of commercial revenue for the LTM, an investor avoids overpaying for the asset.